Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.66 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.50 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7089932 | 1.00 | PLA2G2A (0.66) | PLA2G2ASMPD1TP53TSHRPLA2G4B | |
| SCHEMBL19829354 | 1.00 | PLA2G2A (0.66) | PLA2G2ASMPD1TP53TSHRPLA2G4B | |
| SCHEMBL2710788 | 1.00 | PLA2G2A (0.66) | PLA2G2ASMPD1TP53TSHRPLA2G4B | |
| SCHEMBL9402623 | 1.00 | PLA2G2A (0.66) | PLA2G2ASMPD1TP53TSHRPLA2G4B | |
| SCHEMBL15956200 | 1.00 | PLA2G2A (0.66) | PLA2G2ASMPD1TP53TSHRPLA2G4B | |
| SCHEMBL17413301 | 0.98 | PLA2G2A (0.63) | PLA2G2ASMPD1TP53TSHRPLA2G4B | |
| SCHEMBL25328188 | 0.97 | PLA2G2A (0.71) | PLA2G2ASMPD1TP53TSHRPLA2G4B | |
| SCHEMBL317989 | 0.97 | PLA2G2A (0.71) | PLA2G2ASMPD1TP53TSHRPLA2G4B | |
| SCHEMBL971768 | 0.97 | PLA2G2A (0.71) | PLA2G2ASMPD1TP53TSHRPLA2G4B | |
| SCHEMBL25327393 | 0.97 | PLA2G2A (0.71) | PLA2G2ASMPD1TP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2316819-B1 | Self-assembled nanostructures | XEROX CORP (US) | 2017-11-08 | — | — | EP | disclosed |
| US-8980925-B2 | Antimicrobial amphiphiles and methods for their use | JAMES MADISON INNOVATIONS, INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-20140148487-A1 | ANTIMICROBIAL AMPHIPHILES AND METHODS FOR THEIR USE | James Madison Innovations, Inc, (US) | 2014-05-29 | — | — | US | disclosed |
| US-8703988-B2 | Self-assembled nanostructures | XEROX CORPORATION (US) | 2014-04-22 | — | — | US | disclosed |
| WO-2012054695-A1 | NTIMICROBIAL AMPHIPHILES AND METHODS FOR THEIR USE | JAMES MADISON INNOVATIONS, INC. (US) | 2012-04-26 | — | — | WO | disclosed |
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-12-22 | — | — | US | disclosed |
| EP-2316819-A2 | Self-assembled nanostructures | Xerox Corporation (US) | 2011-05-04 | — | — | EP | disclosed |
| US-20070196407-A1 | Alkoxyphenylcarboxylic acid derivatives | CHIBA SPECIALTY CHEMICALS CORP. | 2007-08-23 | — | — | US | disclosed |
| US-20070196407-A1 | Alkoxyphenylcarboxylic acid derivatives | CHIBA SPECIALTY CHEMICALS CORP. | 2007-08-23 | — | — | US | disclosed |
| US-20070196407-A1 | Alkoxyphenylcarboxylic acid derivatives | CHIBA SPECIALTY CHEMICALS CORP. | 2007-08-23 | — | — | US | disclosed |
| EP-1715832-A1 | ALKOXYPHENYLCARBOXYLIC ACID DERIVATIVES | Ciba SC Holding AG (CH) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005079744-A1 | ALKOXYPHENYLCARBOXYLIC ACID DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148487-A1 | ANTIMICROBIAL AMPHIPHILES AND METHODS FOR THEIR USE | ANXA5, ANXA4, ANXA6 | PLA2G2A 221/4885SMPD1 132/4885TP53 3759/4885 |
| US-20070196407-A1 | Alkoxyphenylcarboxylic acid derivatives | C9, C1S, C5 | PLA2G2A 813/4885SMPD1 641/4885TP53 1042/4885 |
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | ARG1, H1-3, H1-4 | PLA2G2A 1802/4885SMPD1 4475/4885TP53 992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.